Swiss drugmaker Novartis to spin off generics unit Sandoz
Swiss pharmaceuticals company Novartis says it plans to spin off its generics subsidiary Sandoz, which generated nearly $10 billion in revenue last year
More from Illinois Business
Illinois Farmer Today
Corn rootworm possesses 'secret weapon' to survive winter
Illinois Business
•
Aug 5, 2025